These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10895331)

  • 41. High-hyperdiploidy in Philadelphia positive adult acute lymphoblastic leukaemia: case-series and review of literature.
    Tauro S; McMullan D; Griffiths M; Craddock C; Mahendra P
    Bone Marrow Transplant; 2003 May; 31(9):763-6. PubMed ID: 12732882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
    Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunophenotypic analysis of Philadelphia chromosome positive acute lymphoblastic leukaemia in adults].
    Chen HY; Ge Z; Wu YJ; Wu LY; Sun M; Tian T; Qiou HR; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):714-7. PubMed ID: 20561435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
    Hatta Y; Mizuta S; Matsuo K; Ohtake S; Iwanaga M; Sugiura I; Doki N; Kanamori H; Ueda Y; Yoshida C; Dobashi N; Maeda T; Yujiri T; Monma F; Ito Y; Hayakawa F; Takeuchi J; Kiyoi H; Miyazaki Y; Naoe T
    Ann Hematol; 2018 Sep; 97(9):1535-1545. PubMed ID: 29694642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
    Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
    Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
    Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
    Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of Philadelphia chromosome positive acute lymphoblastic leukemia with partial trisomy of chromosome 1q involving chromosome 13 as the acceptor-A novel cytogenetic finding.
    Bharadwaj M; Sharma A; Katara R; Pradhan D; Arora R; Mittal R; Mohanty SK
    Pathol Res Pract; 2017 Jan; 213(1):72-74. PubMed ID: 27894622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
    Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recognition of Philadelphia chromosome-like acute lymphoblastic leukemia as part of routine diagnostic work-up.
    Podgornik H; Doplihar Kebe A; Klun J; Reberšek K; Šućurović S; Škerget M; Zver S
    Int J Lab Hematol; 2022 Feb; 44(1):142-149. PubMed ID: 34491616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.
    Ohyashiki K; Ohyashiki JH; Toyama K
    Leuk Lymphoma; 1993 Jan; 9(1-2):43-8. PubMed ID: 8477200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testicular relapse in Philadelphia chromosome positive acute lymphoblastic leukaemia.
    O'Brien DV; Craig JM; Secker-Walker LM; Boughton BJ
    Acta Haematol; 1993; 89(2):100-3. PubMed ID: 8503240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
    Janssen JW; Fonatsch C; Ludwig WD; Rieder H; Maurer J; Bartram CR
    Leukemia; 1992 May; 6(5):463-4. PubMed ID: 1593911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia.
    van Rhee F; Kasprzyk A; Jamil A; Dickinson H; Lin F; Cross NC; Galvin MC; Goldman JM; Secker-Walker LM
    Br J Haematol; 1995 May; 90(1):225-8. PubMed ID: 7786793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Milone JH; Enrico A
    Leuk Lymphoma; 2009 Dec; 50 Suppl 2():9-15. PubMed ID: 20017606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
    Jabbour E; Kantarjian H; Ravandi F; Thomas D; Huang X; Faderl S; Pemmaraju N; Daver N; Garcia-Manero G; Sasaki K; Cortes J; Garris R; Yin CC; Khoury JD; Jorgensen J; Estrov Z; Bohannan Z; Konopleva M; Kadia T; Jain N; DiNardo C; Wierda W; Jeanis V; O'Brien S
    Lancet Oncol; 2015 Nov; 16(15):1547-1555. PubMed ID: 26432046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Philadelphia chromosome positive acute lymphoblastic leukemia showing normal karyotype in G-banding chromosomal examination before chemotherapy.
    Hato A; Murayama T; Nishikawa S; Kajimoto K; Gomyo H; Sugimoto T; Mizuno I; Koizumi T
    Hematology; 2005 Oct; 10(5):379-81. PubMed ID: 16273725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytogenetic findings in acute biphenotypic leukaemia.
    Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
    Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
    Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.